Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

Mengxiao Yu, Jiancheng Zhou, Bujie Du, Xuhui Ning, Craig Authement, Leah Gandee, Payal Kapur, Jer Tsong Hsieh, Jie Zheng

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

As a "silent killer", kidney disease is often hardly detected at an early stage but can cause lethal kidney failure later on. Thus, a preclinical imaging technique that can readily differentiate between the stages of kidney dysfunction is highly desired for improving our fundamental understanding of kidney disease progression. Herein, we report that in vivo fluorescence imaging, enabled by renal-clearable near-infrared-emitting gold nanoparticles, can noninvasively detect kidney dysfunction, report on the dysfunctional stages, and even reveal adaptive function in a mouse model of unilateral obstructive nephropathy, which cannot be diagnosed with routine kidney function markers. These results demonstrate that low-cost fluorescence kidney functional imaging is highly sensitive and useful for the longitudinal, noninvasive monitoring of kidney dysfunction progression in preclinical research.

Original languageEnglish (US)
Pages (from-to)2787-2791
Number of pages5
JournalAngewandte Chemie - International Edition
Volume55
Issue number8
DOIs
StatePublished - Feb 18 2016

Fingerprint

Gold
Nanoparticles
Imaging techniques
Fluorescence
Infrared radiation
Monitoring
Costs

Keywords

  • fluorescence imaging
  • imaging agents
  • kidney disease
  • kidney dysfunction
  • nanoparticles

ASJC Scopus subject areas

  • Chemistry(all)
  • Catalysis

Cite this

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles. / Yu, Mengxiao; Zhou, Jiancheng; Du, Bujie; Ning, Xuhui; Authement, Craig; Gandee, Leah; Kapur, Payal; Hsieh, Jer Tsong; Zheng, Jie.

In: Angewandte Chemie - International Edition, Vol. 55, No. 8, 18.02.2016, p. 2787-2791.

Research output: Contribution to journalArticle

Yu, Mengxiao ; Zhou, Jiancheng ; Du, Bujie ; Ning, Xuhui ; Authement, Craig ; Gandee, Leah ; Kapur, Payal ; Hsieh, Jer Tsong ; Zheng, Jie. / Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles. In: Angewandte Chemie - International Edition. 2016 ; Vol. 55, No. 8. pp. 2787-2791.
@article{319eae4b965d43bebd96b966101d54d4,
title = "Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles",
abstract = "As a {"}silent killer{"}, kidney disease is often hardly detected at an early stage but can cause lethal kidney failure later on. Thus, a preclinical imaging technique that can readily differentiate between the stages of kidney dysfunction is highly desired for improving our fundamental understanding of kidney disease progression. Herein, we report that in vivo fluorescence imaging, enabled by renal-clearable near-infrared-emitting gold nanoparticles, can noninvasively detect kidney dysfunction, report on the dysfunctional stages, and even reveal adaptive function in a mouse model of unilateral obstructive nephropathy, which cannot be diagnosed with routine kidney function markers. These results demonstrate that low-cost fluorescence kidney functional imaging is highly sensitive and useful for the longitudinal, noninvasive monitoring of kidney dysfunction progression in preclinical research.",
keywords = "fluorescence imaging, imaging agents, kidney disease, kidney dysfunction, nanoparticles",
author = "Mengxiao Yu and Jiancheng Zhou and Bujie Du and Xuhui Ning and Craig Authement and Leah Gandee and Payal Kapur and Hsieh, {Jer Tsong} and Jie Zheng",
year = "2016",
month = "2",
day = "18",
doi = "10.1002/anie.201511148",
language = "English (US)",
volume = "55",
pages = "2787--2791",
journal = "Angewandte Chemie - International Edition",
issn = "1433-7851",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

AU - Yu, Mengxiao

AU - Zhou, Jiancheng

AU - Du, Bujie

AU - Ning, Xuhui

AU - Authement, Craig

AU - Gandee, Leah

AU - Kapur, Payal

AU - Hsieh, Jer Tsong

AU - Zheng, Jie

PY - 2016/2/18

Y1 - 2016/2/18

N2 - As a "silent killer", kidney disease is often hardly detected at an early stage but can cause lethal kidney failure later on. Thus, a preclinical imaging technique that can readily differentiate between the stages of kidney dysfunction is highly desired for improving our fundamental understanding of kidney disease progression. Herein, we report that in vivo fluorescence imaging, enabled by renal-clearable near-infrared-emitting gold nanoparticles, can noninvasively detect kidney dysfunction, report on the dysfunctional stages, and even reveal adaptive function in a mouse model of unilateral obstructive nephropathy, which cannot be diagnosed with routine kidney function markers. These results demonstrate that low-cost fluorescence kidney functional imaging is highly sensitive and useful for the longitudinal, noninvasive monitoring of kidney dysfunction progression in preclinical research.

AB - As a "silent killer", kidney disease is often hardly detected at an early stage but can cause lethal kidney failure later on. Thus, a preclinical imaging technique that can readily differentiate between the stages of kidney dysfunction is highly desired for improving our fundamental understanding of kidney disease progression. Herein, we report that in vivo fluorescence imaging, enabled by renal-clearable near-infrared-emitting gold nanoparticles, can noninvasively detect kidney dysfunction, report on the dysfunctional stages, and even reveal adaptive function in a mouse model of unilateral obstructive nephropathy, which cannot be diagnosed with routine kidney function markers. These results demonstrate that low-cost fluorescence kidney functional imaging is highly sensitive and useful for the longitudinal, noninvasive monitoring of kidney dysfunction progression in preclinical research.

KW - fluorescence imaging

KW - imaging agents

KW - kidney disease

KW - kidney dysfunction

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84958762880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958762880&partnerID=8YFLogxK

U2 - 10.1002/anie.201511148

DO - 10.1002/anie.201511148

M3 - Article

C2 - 26800513

AN - SCOPUS:84958762880

VL - 55

SP - 2787

EP - 2791

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 8

ER -